Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 2, 2023
The
role
of
adaptive
SARS-CoV-2
specific
immunity
in
post-acute
sequelae
COVID-19
(PASC)
is
not
well
explored,
although
a
growing
population
convalescent
patients
with
manifestation
PASC
observed.
We
analyzed
the
SARS-CoV-2-specific
immune
response,
via
pseudovirus
neutralizing
assay
and
multiparametric
flow
cytometry
40
non-specific
15
healthy
donors.
Although
frequencies
SARS-CoV-2-reactive
CD4+
T
cells
were
similar
between
studied
cohorts,
stronger
reactive
CD8+
cell
characterized
by
IFNγ
production
predominant
TEMRA
phenotype
but
low
functional
TCR
avidity
was
detected
compared
to
controls.
Of
interest,
high
comparable
groups
demonstrating
sufficient
cellular
antiviral
response
PASC.
In
line
immunity,
capacity
inferior
conclusion,
our
data
suggest
that
may
be
driven
an
inflammatory
triggered
expanded
pro-inflammatory
cells.
These
are
known
activated
or
even
without
stimulation
lead
tissue
damage.
Further
studies
including
animal
models
required
for
better
understanding
underlying
immunopathogensis.
Summary:
A
persistent
responsible
observed
patients.
Science,
Journal Year:
2024,
Volume and Issue:
383(6680)
Published: Jan. 18, 2024
Long
Covid
is
a
debilitating
condition
of
unknown
etiology.
We
performed
multimodal
proteomics
analyses
blood
serum
from
COVID-19
patients
followed
up
to
12
months
after
confirmed
severe
acute
respiratory
syndrome
coronavirus
2
infection.
Analysis
>6500
proteins
in
268
longitudinal
samples
revealed
dysregulated
activation
the
complement
system,
an
innate
immune
protection
and
homeostasis
mechanism,
individuals
experiencing
Covid.
Thus,
active
was
characterized
by
terminal
system
dysregulation
ongoing
alternative
classical
pathways,
latter
associated
with
increased
antibody
titers
against
several
herpesviruses
possibly
stimulating
this
pathway.
Moreover,
markers
hemolysis,
tissue
injury,
platelet
activation,
monocyte-platelet
aggregates
were
Machine
learning
thromboinflammatory
as
top
biomarkers,
warranting
diagnostic
therapeutic
interrogation
these
systems.
Trends in Endocrinology and Metabolism,
Journal Year:
2023,
Volume and Issue:
34(6), P. 321 - 344
Published: April 19, 2023
Acute
COVID-19
infection
is
followed
by
prolonged
symptoms
in
approximately
one
ten
cases:
known
as
Long
COVID.
The
disease
affects
~65
million
individuals
worldwide.
Many
pathophysiological
processes
appear
to
underlie
COVID,
including
viral
factors
(persistence,
reactivation,
and
bacteriophagic
action
of
SARS
CoV-2);
host
(chronic
inflammation,
metabolic
endocrine
dysregulation,
immune
autoimmunity);
downstream
impacts
(tissue
damage
from
the
initial
infection,
tissue
hypoxia,
dysbiosis,
autonomic
nervous
system
dysfunction).
These
mechanisms
culminate
long-term
persistence
disorder
characterized
a
thrombotic
endothelialitis,
endothelial
hyperactivated
platelets,
fibrinaloid
microclots.
abnormalities
blood
vessels
coagulation
affect
every
organ
represent
unifying
pathway
for
various
The Lancet Respiratory Medicine,
Journal Year:
2023,
Volume and Issue:
11(8), P. 739 - 754
Published: July 17, 2023
Individuals
with
SARS-CoV-2
infection
can
develop
symptoms
that
persist
well
beyond
the
acute
phase
of
COVID-19
or
emerge
after
phase,
lasting
for
weeks
months
initial
illness.
The
post-acute
sequelae
COVID-19,
which
include
physical,
cognitive,
and
mental
health
impairments,
are
known
collectively
as
long
COVID
post-COVID-19
condition.
substantial
burden
this
multisystem
condition
is
felt
at
individual,
health-care
system,
socioeconomic
levels,
on
an
unprecedented
scale.
Survivors
COVID-19-related
critical
illness
risk
respiratory
distress
syndrome,
sepsis,
chronic
illness,
these
multidimensional
morbidities
might
be
difficult
to
differentiate
from
specific
effects
COVID-19.
We
provide
overview
manifestations
in
adults.
explore
various
organ
systems,
describe
potential
pathophysiological
mechanisms,
consider
challenges
providing
clinical
care
support
survivors
manifestations.
Research
needed
reduce
incidence
optimise
therapeutic
rehabilitative
patients.
Journal of Microbiology Immunology and Infection,
Journal Year:
2022,
Volume and Issue:
56(1), P. 1 - 9
Published: Oct. 15, 2022
At
present,
there
are
more
than
560
million
confirmed
cases
of
the
coronavirus
disease
2019
(COVID-19)
worldwide.
Although
98%
patients
with
severe
acute
respiratory
syndrome-coronavirus
2
(SARS-CoV-2)
infection
can
survive
COVID,
a
significant
portion
survivors
develop
residual
health
problems,
which
is
termed
as
long
COVID.
COVID-19
generally
associated
high
risk
asymptomatic
or
mild
also
show
The
definition
COVID
inconsistent
and
its
clinical
manifestations
protean.
In
addition
to
general
symptoms,
such
fatigue,
affect
many
organ
systems,
including
respiratory,
neurological,
psychosocial,
cardiovascular,
gastrointestinal,
metabolic
systems.
Moreover,
may
experience
exercise
intolerance
impaired
daily
function
quality
life.
Long
be
caused
by
SARS-CoV-2
direct
injury
immune/inflammatory
response.
Assessment
requires
comprehensive
evaluation,
history
taking,
physical
examination,
laboratory
tests,
radiography,
functional
tests.
However,
no
known
effective
treatment
for
Based
on
limited
evidence,
vaccines
help
prevent
development
As
new
entity
that
constantly
evolving,
still
unknowns,
further
investigation
warranted
enhance
our
understanding
this
disease.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: April 20, 2023
Post-Acute
Sequelae
of
Severe
Acute
Respiratory
Syndrome
Coronavirus
-
2
(SARS-CoV-2)
infection,
or
Long
COVID,
is
a
prevailing
second
pandemic
with
nearly
100
million
affected
individuals
globally
and
counting.
We
propose
visual
description
the
complexity
COVID
its
pathogenesis
that
can
be
used
by
researchers,
clinicians,
public
health
officials
to
guide
global
effort
toward
an
improved
understanding
eventual
mechanism-based
provision
care
afflicted
patients.
The
proposed
visualization
framework
for
should
evidence-based,
dynamic,
modular,
systems-level
approach
condition.
Furthermore,
further
research
such
could
establish
strength
relationships
between
pre-existing
conditions
(or
risk
factors),
biological
mechanisms,
resulting
clinical
phenotypes
outcomes
COVID.
Notwithstanding
significant
contribution
disparities
in
access
social
determinants
have
on
disease
course
long
our
model
focuses
primarily
mechanisms.
Accordingly,
sets
out
scientific,
clinical,
efforts
better
understand
abrogate
burden
imposed
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 28, 2024
The
COVID-19
pandemic
continues
to
cause
severe
global
disruption,
resulting
in
significant
excess
mortality,
overwhelming
healthcare
systems,
and
imposing
substantial
social
economic
burdens
on
nations.
While
most
of
the
attention
therapeutic
efforts
have
concentrated
acute
phase
disease,
a
notable
proportion
survivors
experience
persistent
symptoms
post-infection
clearance.
This
diverse
set
symptoms,
loosely
categorized
as
long
COVID,
presents
potential
additional
public
health
crisis.
It
is
estimated
that
1
5
exhibit
clinical
manifestations
consistent
with
COVID.
Despite
this
prevalence,
mechanisms
pathophysiology
COVID
remain
poorly
understood.
Alarmingly,
evidence
suggests
cases
within
condition
develop
debilitating
or
disabling
symptoms.
Hence,
urgent
priority
should
be
given
further
studies
equip
systems
for
its
management.
review
provides
an
overview
available
information
emerging
condition,
focusing
affected
individuals’
epidemiology,
pathophysiological
mechanisms,
immunological
inflammatory
profiles.
Seminars in Thrombosis and Hemostasis,
Journal Year:
2023,
Volume and Issue:
50(02), P. 288 - 294
Published: May 19, 2023
Abstract
The
prevailing
hypotheses
for
the
persistent
symptoms
of
Long
COVID
have
been
narrowed
down
to
immune
dysregulation
and
autoantibodies,
widespread
organ
damage,
viral
persistence,
fibrinaloid
microclots
(entrapping
numerous
inflammatory
molecules)
together
with
platelet
hyperactivation.
Here
we
demonstrate
significantly
increased
concentrations
von
Willebrand
factor
(VWF),
4
(PF4),
serum
amyloid
A
(SAA),
α-2
antiplasmin
(α-2AP),
endothelial-leukocyte
adhesion
molecule
1
(E-selectin),
endothelial
cell
(PECAM-1)
in
soluble
part
blood.
It
was
noteworthy
that
mean
level
exceeded
upper
limit
laboratory
reference
range
patients,
other
5
were
elevated
patients
as
compared
controls.
This
is
alarming
if
take
into
consideration
a
significant
amount
total
burden
these
molecules
has
previously
shown
be
entrapped
inside
fibrinolysis-resistant
(thus
decreasing
apparent
molecules).
We
conclude
presence
microclotting,
relatively
high
levels
six
biomarkers
known
key
drivers
clotting
pathology,
points
thrombotic
endothelialitis
pathological
process
COVID.